<DOC>
	<DOCNO>NCT00195364</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety etanercept patient rheumatoid arthritis successfully complete open-label safety study 0881A1-301-EU</brief_summary>
	<brief_title>Study Evaluating Etanercept Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU Spain</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>To complete 0881A1301EU study Spain Clinical diagnosis ACR revise criterion rheumatoid arthritis . Hypersensibility etanercept component Significant concurrent medical disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>